BIOS Capital Management, LP's Net Worth
$17.3 Million
Who is BIOS Capital Management, LP?
BIOS Capital Management, LP has an estimated net worth of $17.3 Million. This is based on reported shares across multiple companies, which include COGNITION THERAPEUTICS INC, IN8BIO, INC., Lantern Pharma Inc., and Azitra Inc.
SEC CIK
BIOS Capital Management, LP's CIK is 0001813845
Past Insider Trading and Trends
2022 was BIOS Capital Management, LP's most active year for acquiring shares with 32 total transactions. BIOS Capital Management, LP's most active month to acquire stocks was the month of July. 2022 was BIOS Capital Management, LP's most active year for disposing of shares, totalling 12 transactions. BIOS Capital Management, LP's most active month to dispose stocks was the month of May. 2022 saw BIOS Capital Management, LP paying a total of $5,978,214.27 for 3,694,357 shares, this is the most they've acquired in one year. In 2022 BIOS Capital Management, LP cashed out on 458,307 shares for a total of $1,573,514.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Lantern Pharma Inc. (LTRN) Snapshot price: $4.255
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.63% | -30.00K |
$6.30 | -$189,100.00 | 618.21K |
May 23 - May 24
| |||
Form 4
| -18.18% | -144.00K |
$4.70 | -$676,294.06 | 648.21K |
Feb 27 - Feb 29
| |||
Form 4
| +2.61% | 20.13K |
$3.67 | $1.93 | 792.21K |
Jan 17
| |||
Form 4
| -19.78% | -145.35K |
$3.44 | -$499,997.12 | 589.5K |
Nov 29
| |||
Form 4
| -18.85% | -350.00K |
$4.40 | -$1,540,000.00 | 1.51M |
Nov 8
| |||
Form 4
| +54.07% | 26.09K |
$3.12 | $0.14 | 74.35K |
Sep 2
| |||
Form 4
| +12.00% | 95.78K |
$3.13 | $299,788.27 | 893.94K |
Mar 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 4
| |||
Form 4
| +478.38% | 1.46M |
—
|
—
| 1.76M |
Jun 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
IN8BIO, INC. (INAB) Snapshot price: $1.23
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
| +1.55% | 75K |
$2.48 | $185,912.48 | 4.9M |
Dec 12
| |||
Form 4
| +0.52% | 25K |
$2.02 | $50,535.00 | 4.83M |
Sep 28
| |||
Form 4
| +1.06% | 50K |
$1.93 | $96,500.00 | 4.75M |
Aug 17
| |||
Form 4
| +69.31% | 1.77M |
$1.90 | $3,369,999.60 | 4.33M |
Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 13
| |||
Form 4
|
∞
| 6.63M |
—
|
—
| 6.63M |
Aug 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
COGNITION THERAPEUTICS INC (CGTX) Snapshot price: $2.31
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +141.67% | 8.5K |
—
|
—
| 14.5K |
Jun 7
| |||
Form 4
|
∞
| 500.1K |
$1.05 | $525,099.75 | 500.1K |
Nov 8
| |||
Form 4
|
∞
| 6K |
—
|
—
| 6K |
Jun 9
| |||
Form 4
| +0.61% | 16.06K |
$2.65 | $42,564.78 | 2.66M |
Nov 28
| |||
Form 4
| +2.76% | 71K |
$1.40 | $99,400.00 | 2.64M |
Nov 16
| |||
Form 4
| +140.01% | 1.5M |
$1.20 | $1,800,000.00 | 2.57M |
Nov 15
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4/A
|
∞
| 1.42M |
—
|
—
| 1.42M |
Oct 13
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Azitra Inc (AZTR) Snapshot price: $1.06
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +893.90% | 5.98M |
$5.00 |
—
| 6.65M |
Jun 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |